2012China Modern MedicineRequires access

Effect observation on atorvastatin in the treatment of patients with cerebral infarction

Song Yanling

Open publisher page 0 citations

Abstract

Objective To investigate the effect of atorvastatin in the treatment of patients with cerebral infarction. Methods One hundred and fourteen patients with cerebral infarction were selected in the hospital from October 2009 to October 2011, who were randomly divided into two groups. Fifty-seven patients used conventional treatment as the control group. On the basis of routine treatment, 57 patients used atorvastatin (20 mg/time, 1 time/d, oral 14 d) in the treatment as the observation group. Course of treatment was two weeks. Clinical indicators and the scores of neurological deficit were compared between two groups after treatment. Results Hypersensitive C reactive protein levels, levels of matrix metalloproteinase-9, the scores of neurological deficit, recurrence rate in the observation group were significantly lower than those in the control group. Patient satisfaction in the observation group was significantly higher than that in the control group. The difference was statistically significant (P 0.05). Conclusion Atorvastatin in the treatment for patients with cerebral infarction has obvious curative effect, which not only can reduce inflammation in the body and improve atherosclerotic condition of patients, but also can improve the neurological function. That is worthy of clinical use.

About this research paper

What this paper is about

Objective To investigate the effect of atorvastatin in the treatment of patients with cerebral infarction. Methods One hundred and fourteen patients with cerebral infarction were selected in the hospital from October 2009 to October 2011, who were randomly divided into two groups. Fifty-seven patients used conventional treatment as the control group. On the basis of routine treatment, 57 patients used atorvastatin (20 mg/time, 1 time/d, oral 14 d) in the treatment as the observation group. Course of treatment was two weeks. Clinical indicators and the scores of neurological deficit were compared between two groups after treatment. Results Hypersensitive C reactive protein levels, levels of matrix metalloproteinase-9, the scores of neurological deficit, recurrence rate in the observation group were significantly lower than those in the control group. Patient satisfaction in the observation group was significantly higher than that in the control group. The difference was statistically significant (P 0.05). Conclusion Atorvastatin in the treatment for patients with cerebral infarction has obvious curative effect, which not only can reduce inflammation in the body and improve atherosclerotic condition of patients, but also can improve the neurological function. That is worthy of clinical use.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the effect of atorvastatin in the treatment of patients with cerebral infarction. Methods One hundred and fourteen patients with cerebral infarction were selected in the hospital from October 2009 to October 2011, who were randomly divided into two groups. Fifty-seven patients used conventional treatment as the control group. On the basis of routine treatment, 57 patients used atorvastatin (20 mg/time, 1 time/d, oral 14 d) in the treatment as the observation group. Course of treatment was two weeks. Clinical indicators and the scores of neurological deficit were compared between two groups after treatment. Results Hypersensitive C reactive protein levels, levels of matrix metalloproteinase-9, the scores of neurological deficit, recurrence rate in the observation group were significantly lower than those in the control group. Patient satisfaction in the observation group was significantly higher than that in the control group. The difference was statistically significant (P 0.05). Conclusion Atorvastatin in the treatment for patients with cerebral infarction has obvious curative effect, which not only can reduce inflammation in the body and improve atherosclerotic condition of patients, but also can improve the neurological function. That is worthy of clinical use.

Key concepts: Medicine, Atorvastatin, Neurological deficit, Cerebral infarction, Conventional treatment, Infarction, Treatment and control groups, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect observation on atorvastatin in the treatment of patients with cerebral infarction — Research Paper | ScholarLens